AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

Retrospective AI analysis of AMARANTH data revealed a 46% slower decline in slow-progressors treated with lanabecestat, prompting NHS Innovation East England to fund clinical integration.